Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Quality of Life × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 356 Stomach Neoplasms 249 Rectal Neoplasms 233 Colonic Neoplasms 168 Pancreatic Neoplasms 141 Neoplasm Metastasis 89 Esophageal Neoplasms 75 Neoplasms 57 Carcinoma, Hepatocellular 49 Adenocarcinoma Of Esophagus 42 Adenocarcinoma 42 Lymphoma, Large B-Cell, Diffuse 40 Cholangiocarcinoma 38 Carcinoma, Non-Small-Cell Lung 33 Biliary Tract Neoplasms 29 Gallbladder Neoplasms 25 Gastrointestinal Neoplasms 24 Recurrence 23 Liver Neoplasms 21 Esophageal Squamous Cell Carcinoma 20 Breast Neoplasms 20 Ovarian Neoplasms 17 Bile Duct Neoplasms 17 Unspecified Adult Solid Tumor, Protocol Specific 13 Peritoneal Neoplasms 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Lung Neoplasms 10 Head and Neck Neoplasms 10 Appendiceal Neoplasms 10 Lymphoma, Non-Hodgkin 9

Interventions

endostar protein 1 coenzyme Q10 1 apatinib 1 Yoga 1 Ubiquinone 1 Tamoxifen 1 Referral and Consultation 1 Palliative Care 1 Oxaliplatin 1 Melatonin 1 Exercise 1 Educational Status 1 Chemoradiotherapy 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03577392 2019-04-04

EXECC

Sichuan Provincial People's Hospital

Phase 2/3 Unknown

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡